Bone Biologics Corp financial data

Symbol
BBLG, BBLGW on Nasdaq
Location
Burlington, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1582% % 16%
Debt-to-equity 6.8% % -15%
Return On Equity -60% % 50%
Return On Assets -56% % 49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,795,260 shares -45%
Common Stock, Shares, Outstanding 1,795,260 shares 265%
Entity Public Float $7,232,186 USD 362%
Common Stock, Value, Issued $1,795 USD 265%
Weighted Average Number of Shares Outstanding, Basic 1,174,869 shares 364%
Weighted Average Number of Shares Outstanding, Diluted 1,174,869 shares 364%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $1,060,191 USD -50%
General and Administrative Expense $2,174,751 USD 4.1%
Operating Income (Loss) $3,234,942 USD 23%
Nonoperating Income (Expense) $125,951 USD 18%
Net Income (Loss) Attributable to Parent $3,108,991 USD 24%
Earnings Per Share, Basic -2.65 USD/shares 91%
Earnings Per Share, Diluted -2.65 USD/shares 91%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $5,796,135 USD 50%
Assets $5,796,135 USD 50%
Liabilities, Current $418,587 USD 11%
Liabilities $418,587 USD 11%
Retained Earnings (Accumulated Deficit) $88,130,369 USD -3.7%
Stockholders' Equity Attributable to Parent $5,377,548 USD 54%
Liabilities and Equity $5,796,135 USD 50%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $926,125 USD 29%
Net Cash Provided by (Used in) Financing Activities $347,549 USD -77%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 1,795,260 shares 265%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $578,576 USD -388%
Deferred Tax Assets, Valuation Allowance $24,811,000 USD 14%
Deferred Tax Assets, Gross $24,811,000 USD 14%
Deferred Tax Assets, Operating Loss Carryforwards $14,145,000 USD 31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $93,506,122 USD 5.7%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%